Clinical Trials for Intas Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Intas Pharmaceuticals

Clinical Trials (1)

NCT03671044
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
PHASE3Recruiting
657 participants
Started: Jul 10, 2018 · Completed: Dec 31, 2025
1 condition3 sponsors4 locations